Thu, November 2, 2017

Jason Mills Maintained (ATRC) at Strong Buy with Decreased Target to $24 on, Nov 2nd, 2017

Jason Mills of Canaccord Genuity, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Decreased Target from $28 to $24 on, Nov 2nd, 2017.

Jason, nor any peers, have made any analyst calls on ATRC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30